NEUP
NEUP clinical trials: Neuphoria Therapeutics Inc.
Every trial on ClinicalTrials.gov where Neuphoria Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 6
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NEUP on the catalyst calendar · NEUP registry changes
- Primary completion Sep 11, 2025ActualPhase 3NCT06510504Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1Bionomics Limited · Social Anxiety DisorderCompletedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 10, 2022ActualPhase 2NCT05193409A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety DisorderBionomics Limited · Social Anxiety DisorderCompletedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 25, 2023ActualPhase 2NCT04951076A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)Bionomics Limited · Post-Traumatic Stress DisorderCompletedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 5, 2018ActualPhase 2NCT02933606Phase II Study of BNC210 in PTSDBionomics Limited · Post-Traumatic Stress DisorderCompletedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2019ActualPhase 2NCT03548194A Study of BNC210 in Elderly Patients With AgitationBionomics Limited · Agitation in the ElderlyCompletedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2017ActualPhase 1NCT02726334A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.Bionomics Limited · Colorectal CancerTerminatedNEUPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2016ActualPhase 1/Phase 2NCT01034631BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell CarcinomaHoosier Cancer Research Network · Renal Cell CarcinomaCompletedNEUPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2014ActualPhase 1/Phase 2NCT01624493BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsHoosier Cancer Research Network · Ovarian CancerWithdrawnNEUPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner